{"abstract":"The U.S. Food and Drug Administration (FDA) is contemplating the grant of an Exclusive Patent License to practice the inventions embodied in the Patents and Patent Applications listed in the SUPPLEMENTARY INFORMATION section of this notice to Sciogen Inc. located in San Jose, California.","action":"Notice.","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"Food and Drug Administration","name":"Food and Drug Administration","id":199,"url":"https://www.federalregister.gov/agencies/food-and-drug-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/199","parent_id":221,"slug":"food-and-drug-administration"}],"body_html_url":"https://www.federalregister.gov/documents/full_text/html/2020/04/27/2020-08879.html","cfr_references":[],"citation":"85 FR 23365","comment_url":null,"comments_close_on":null,"correction_of":null,"corrections":[],"dates":"Only written comments and/or complete applications for a license which are received by the FDA Technology Transfer Program within 15 days from the date of publication of this notice in the Federal Register will be considered.","disposition_notes":null,"docket_ids":["Docket No. FDA-2020-N-0892"],"dockets":[],"document_number":"2020-08879","effective_on":null,"end_page":23366,"executive_order_notes":null,"executive_order_number":null,"full_text_xml_url":"https://www.federalregister.gov/documents/full_text/xml/2020/04/27/2020-08879.xml","html_url":"https://www.federalregister.gov/documents/2020/04/27/2020-08879/prospective-grant-of-an-exclusive-patent-license-development-production-and-commercialization-of-a","images":{},"images_metadata":{},"json_url":"https://www.federalregister.gov/api/v1/documents/2020-08879?publication_date=2020-04-27","mods_url":"https://www.govinfo.gov/metadata/granule/FR-2020-04-27/2020-08879/mods.xml","not_received_for_publication":null,"page_length":2,"page_views":{"count":224,"last_updated":"2026-08-24 22:15:11 -0400"},"pdf_url":"https://www.govinfo.gov/content/pkg/FR-2020-04-27/pdf/2020-08879.pdf","presidential_document_number":null,"proclamation_number":null,"public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2020-08879.pdf?1587732347","publication_date":"2020-04-27","raw_text_url":"https://www.federalregister.gov/documents/full_text/text/2020/04/27/2020-08879.txt","regulation_id_number_info":{},"regulation_id_numbers":[],"regulations_dot_gov_info":{"supporting_documents":[],"comments_url":"https://www.regulations.gov/docketBrowser?rpp=50&so=DESC&sb=postedDate&po=0&dct=PS&D=FDA-2020-N-0892","supporting_documents_count":0,"docket_id":"FDA-2020-N-0892","regulation_id_number":null,"title":"Prospective Grant of an Exclusive Patent License: Development, Production, and Commercialization of a Seasonal Influenza Vaccine","checked_regulationsdotgov_at":"2020-04-29T03:30:18Z"},"regulations_dot_gov_url":null,"significant":null,"signing_date":null,"start_page":23365,"subtype":null,"title":"Prospective Grant of an Exclusive Patent License: Development, Production, and Commercialization of a Seasonal Influenza Vaccine","toc_doc":null,"toc_subject":null,"topics":[],"type":"Notice","volume":85}